Skip to main content
. 2024 Apr 5;5:1307536. doi: 10.3389/fresc.2024.1307536

Table 1.

Most important characteristics of the included studies.

Category Details N (%)*
Year of publication
2015 37 (13.1)
2016 42 (14.8)
2017 23 (8.1)
2018 47 (16.6)
2019 17 (6.0)
2020 28 (9.9)
2021 67 (23.7)
2022 22 (7.7)
Country
United States of America 39 (13.3)
The Netherlands 30 (10.2)
Australia 28 (9.6)
China 24 (8.2)
United Kingdom 16 (5.5)
Korea 14 (4.8)
Spain 13 (4.4)
Denmark 11 (3.8)
Sweden 11 (3.8)
Canada 10 (3.4)
Italy 10 (3.4)
Taiwan 10 (3.4)
Germany 8 (2.7)
Japan 8 (2.7)
Norway 8 (2.7)
Belgium 6 (2.1)
Turkey 5 (1.7)
Others** 34 (15.4)
Total countries 293 (100)
Study design
Intervention study 230 (81.3)
Observational study 36 (12.7)
Descriptive study 17 (6.0)
Age related inclusion criteria
Not reported 97 (34.3)
Older than 65 62 (21.9)
Older than 18 38 (13.4)
Another criterion*** 26 (9.2)
Older than 60 23 (8.1)
Older than 75 8 (2.8)
Older than 70 7 (2.5)
Older than 50 5 (1.7)
Ceiling age at 85 6 (2.1)
Ceiling age at 80 5 (1.7)
Ceiling age at 70 3 (1.1)
Ceiling age at 75 2(0.7)
Ceiling age at 90 1(0.4)
*

Represents the proportion of included studies.

**

Finland, New Zealand, Portugal Chile, France, Mexico, Brazil, Greece, Iran, Singapore, Austria, Bangladesh, Croatia, Cyprus, India, Ireland, Israel, Malaysia, Nepal, Philippines, Poland, Switzerland, Uganda.

***

Refers to infrequent criteria like “between 40 and 67 years" (48) or population-specific criteria. For example, “older 50 or 55 years” for Aboriginal and Torres Strait Islander people (49, 50) or “older than 60 years” in the Netherlands but “older than 80 years” in Switzerland (51); or comorbidities-adjusted age inclusion related criteria like “older than 65 years” in general but between 50 and 64 for people with a chronic health condition (52).